JESSICA LAPP: Open Payments
NPI 1700555786 · PRESTONSBURG, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$336 in 18 payments from 11 companies in 2025. Trend: 2023 $742 · 2024 $483 · 2025 $336
Food & beverage: $336
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 3 | $74 |
| Otsuka America Pharmaceutical, Inc. | 3 | $68 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $55 |
| Axsome Therapeutics, Inc. | 2 | $31 |
| ABBVIE INC. | 1 | $17 |
| Lundbeck LLC | 1 | $16 |
| Neurocrine BioSciences, Inc. | 1 | $16 |
| Alkermes, Inc. | 1 | $16 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
Products named: REXULTI, FANAPT, CAPLYTA, Auvelity, VRAYLAR, INGREZZA, LYBALVI, Jornay PM.
Industry payments across KY — which companies pay providers there.
